In this episode of The UroOnc Minute, Carissa Chu, MD, discusses the prevalence, biology, prognostic significance, and emerging molecular targets of variant histologies in bladder cancer.
Carissa Chu, MD
Advertisement
Articles by Carissa Chu, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves generic Ga-68 PSMA-11 radiodiagnostic for prostate cancer
2
Clinical Application of MMAI Score in Patients with Prostate Cancer
3
Jonathan Harper, MD, shares PUSH trial findings on hydration and stone recurrence
4
Benjamin Lowentritt, MD, reviews real-world testosterone recovery data with relugolix
5